Table 4.

Age-specific seroconversion rates comparing DIG1 with groups receiving a delayed second dose

Age group	DIG1		RR	DIG2 and DIG3		RR
	Inaba
	No. responding	Total		No. responding	Total
1–4*	6	16	37.5%	20	26	76.9%
5–14	13	18	72.2%	30	36	83.3%
> 14**	5	20	25.0%	25	31	80.6%
Overall**	24	54	44.4%	75	93	80.6%
	Ogawa
1–4*	6	16	37.5%	22	26	84.6%
5–14	12	18	66.7%	26	36	72.2%
> 14**	11	20	55.0%	24	31	77.4%
Overall**	29	54	53.7%	72	93	77.4%

DIG = dose-interval.

^*P = 0.01.

** P ≤ 0.001, comparing response rates between DIG1 with DIG2 and DIG3.